Eosinophilic fasciitis secondary to treatment with atorvastatin.
DeGiovanni
C
C
Chard
M
M
Woollons
A
A
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D000069059:Atorvastatin; D004802:Eosinophilia / Q000139:chemically induced*; D005208:Fasciitis / Q000139:chemically induced*; D005260:Female; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D011758:Pyrroles / Q000009:adverse effects*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin